Statement |

138th WHO EB - Draft Global Health sector strategy - Viral Hepatitis - Agenda item 9.2

Médecins Sans Frontières (MSF) is witnessing first-hand the lack of access to reliable diagnostics and affordable medicines for people living with viral hepatitis, especially hepatitis B and C, in several low and middle income developing countries. In particular, MSF is currently implementing viral hepatitis C treatment programs for people co-infected with HIV in India, Myanmar, Iran, Uganda, Kenya and Mozambique, and treating people mono-infected with the hepatitis C virus (HCV) in Pakistan.